DK158644C - Fremgangsmaade til fremstilling af et antistof eller antiserum, anvendelse af denne fremgangsmaade til opnaaelse af pattedyrsceller, der er i stand til at producere et saadant antistof, og anvendelse af det saaledes fremstillede antistof eller antiserum til immunoassay. - Google Patents

Fremgangsmaade til fremstilling af et antistof eller antiserum, anvendelse af denne fremgangsmaade til opnaaelse af pattedyrsceller, der er i stand til at producere et saadant antistof, og anvendelse af det saaledes fremstillede antistof eller antiserum til immunoassay.

Info

Publication number
DK158644C
DK158644C DK164381A DK164381A DK158644C DK 158644 C DK158644 C DK 158644C DK 164381 A DK164381 A DK 164381A DK 164381 A DK164381 A DK 164381A DK 158644 C DK158644 C DK 158644C
Authority
DK
Denmark
Prior art keywords
antibody
procedure
antomely
antiles
antis
Prior art date
Application number
DK164381A
Other languages
English (en)
Other versions
DK164381A (da
DK158644B (da
Inventor
Toshiyuki Hamaoka
Kayoko Tateishi
Original Assignee
Toshiyuki Hamaoka
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP4844780A external-priority patent/JPS56145222A/ja
Priority claimed from JP17276180A external-priority patent/JPS5795919A/ja
Application filed by Toshiyuki Hamaoka filed Critical Toshiyuki Hamaoka
Publication of DK164381A publication Critical patent/DK164381A/da
Publication of DK158644B publication Critical patent/DK158644B/da
Application granted granted Critical
Publication of DK158644C publication Critical patent/DK158644C/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/577—Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies; monoclonal antibodies per se are classified with their corresponding antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/743—Steroid hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6093—Synthetic polymers, e.g. polyethyleneglycol [PEG], Polymers or copolymers of (D) glutamate and (D) lysine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK164381A 1980-04-11 1981-04-10 Fremgangsmaade til fremstilling af et antistof eller antiserum, anvendelse af denne fremgangsmaade til opnaaelse af pattedyrsceller, der er i stand til at producere et saadant antistof, og anvendelse af det saaledes fremstillede antistof eller antiserum til immunoassay. DK158644C (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP4844780A JPS56145222A (en) 1980-04-28 1980-04-11 Improved antibody and its preparation
JP4844780 1980-04-11
JP17276180A JPS5795919A (en) 1980-12-08 1980-12-08 Improved antibody and its preparation
JP17276180 1980-12-08

Publications (3)

Publication Number Publication Date
DK164381A DK164381A (da) 1981-10-12
DK158644B DK158644B (da) 1990-06-25
DK158644C true DK158644C (da) 1990-11-19

Family

ID=26388721

Family Applications (1)

Application Number Title Priority Date Filing Date
DK164381A DK158644C (da) 1980-04-11 1981-04-10 Fremgangsmaade til fremstilling af et antistof eller antiserum, anvendelse af denne fremgangsmaade til opnaaelse af pattedyrsceller, der er i stand til at producere et saadant antistof, og anvendelse af det saaledes fremstillede antistof eller antiserum til immunoassay.

Country Status (4)

Country Link
DE (1) DE3114362C2 (da)
DK (1) DK158644C (da)
FR (1) FR2480782A1 (da)
GB (1) GB2075987B (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0091760B1 (en) * 1982-04-09 1986-07-02 FUJIREBIO KABUSHIKI KAISHA also trading as FUJIREBIO INC. Anti immune complex antibody and preparation thereof
US4468346A (en) * 1983-10-27 1984-08-28 The United States Of America As Represented By The Secretary Of Agriculture Monoclonal antibodies to porcine immunoglobulins
DE3507849A1 (de) * 1985-03-06 1986-09-11 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren und reagenz zur bestimmung des follikel stimulierenden hormons sowie hierzu geeignete monoklonale antikoerper
DE3507848A1 (de) * 1985-03-06 1986-11-13 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren und reagenz zur bestimmung des luteinisierenden hormons sowie hierzu geeignete monoklonale antikoerper
US4772551A (en) * 1985-12-26 1988-09-20 Neogen Corporation Method and test kit for detecting a trichothecene using novel monoclonal antibodies
EP0258322A1 (en) * 1986-02-26 1988-03-09 The University Of Melbourne Hla-b27 testing
IE74193B1 (en) * 1990-08-23 1997-07-16 Enfer Tech Ltd Hormone detection methods
CA2130386A1 (en) * 1993-08-25 1995-02-26 Diana Kathryn Baisden Monoclonal antibodies specific for 5-dihydrotestosterone

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51101120A (en) * 1975-02-28 1976-09-07 Dai Ichi Kogyo Seiyaku Co Ltd Kogen oyobi kotainoseiho
US4191668A (en) * 1977-02-03 1980-03-04 Scripps Clinic And Research Foundation Induction of immunological tolerance

Also Published As

Publication number Publication date
DK164381A (da) 1981-10-12
FR2480782B1 (da) 1984-06-01
DK158644B (da) 1990-06-25
GB2075987A (en) 1981-11-25
DE3114362A1 (de) 1982-03-18
FR2480782A1 (fr) 1981-10-23
DE3114362C2 (de) 1983-08-18
GB2075987B (en) 1983-06-02

Similar Documents

Publication Publication Date Title
DK157026C (da) Fremgangsmaade til fremstilling af 7-oed-alfa-amino-alfa-(p-hydroxy-phenyl)acetamidoaa-3-methyl-cephem-4-carboxylsyre
NO812358L (no) Fremgangsmaate for modifisering av karbohydrater.
IT7824577A0 (it) Metodo per la produzione di anticorpi.
DK301077A (da) Fremgangsmade til fremstilling af 6a,10a-transhexahydrodibenzo (b,d) pyran-9-oner
DK188481A (da) Fremgangsmaade til fremstilling af et organisk platinkompleks
NO144425C (no) Fremgangsmaate ved fremstilling av raakobber.
NO159736C (no) Hydrogenutviklingste ved fremstill ing av denne.
DK259477A (da) Fremgangsmade til fremstilling af hidtil ukendte gona-4,9(10)-diener
DK158644C (da) Fremgangsmaade til fremstilling af et antistof eller antiserum, anvendelse af denne fremgangsmaade til opnaaelse af pattedyrsceller, der er i stand til at producere et saadant antistof, og anvendelse af det saaledes fremstillede antistof eller antiserum til immunoassay.
DK305578A (da) Fremgangsmaade til fremstilling af bicycliske thia-diaza-forbindelser isaer 1,3-diaza-cyclopent-2-eno(2,1-b) (1-thia-3-aza-cycloalkaner).
DK377577A (da) Fremgangsmaade til fremstilling af antiserum
NO771104L (no) Fremgangsm}te for dyrkning av celler.
DK93481A (da) Fremgangsmaade til fremstilling af 7-oxo-1-azabicyclo (3.2.0) hept-2-en-carboxylsyre
DK476277A (da) Fremgangsmaade til fremstilling af krydslaminater
DK139029B (da) Analogifremgangsmåde til fremstilling af 5-m-tolyloxyuracil.
DK461381A (da) Fremgangsmaade til fremstilling af 6-substituerede 6h-dibenzo (b,d) pyranderivater
DK245677A (da) Apparat til fremstilling af sammensatte bjelker
DK144912C (da) Fremgangsmaade til fremstilling af substituerede 2,6-methano-3,4,5,6-tetrahydro-2h-1-benzoxociner
IS2410A7 (is) Aðferð til þess að framleiða Heparin
DK154560C (da) Fremgangsmaade til fremstilling af radioaktivt maerket 8-oe4-oe4-(2-pyrimidinyl)-1-piperazinylaabutylaa-8-azaspiro-oe4.5aadekan-7,9-dion
DK513580A (da) Fremgangsmaade til fremstilling af 4,5-diaryl-alfa (polyhalogenalkyl)-1h-imidazol-2-methanoler
DK263577A (da) Fremgangsmade til fremstilling af substituerede 2-v-nyl-chromoner
DK37382A (da) Fremgangsmaade til fremstilling af hybridceller,der producereret antistof,fremgangsmaade til fremstilling af antistoffer samt hybridceller og antistoffer
DK159417C (da) Fremgangsmaade til fremstilling af alfa-ketocarboxylsyre-n-tert.butylamider
DK73877A (da) Fremgangsmade til fremstilling af et analgetikum

Legal Events

Date Code Title Description
PBP Patent lapsed
PBP Patent lapsed